The Ledger

Every statement that passed quotation and attribution checks. Mix any filter with any other: certainty 1/5, debate potential 5/5, or both at once.

clear all ✕

why aren't all 5 resolved? a statement only gets an assessment when the public record can support or contradict it. opinions and what-ifs never can, and 0 checkable ones are still open, waiting for their date. predictions held up or didn't; assertions are supported or contradicted. on every card: ▮▮▮▮▮ certainty · ▮▮▮▮▮ debate potential. speakers are clickable

Assertion Supported
Kuruvilla: Philip Morris rates higher in ESG databases than lung cancer drugmakers
“So we have often marveled that Philip Morris, which is a widely known provisioner of cigarettes and tobacco, rates more highly on many of these databases than on companies that are actually trying to treat lung cancer.”
Finny Kuruvilla Oct 12, 2023 ▶ 22:03 Finny Kuruvilla – The Fourth Source of Alpha at Eventide (EP.343)
Assertion Not checkable as stated
Russo: Philip Morris CEO expects $1 billion in savings from big data
“Even Philip Morris, when I met with the CEO in Switzerland in September, suggested that they'd have a billion dollar savings potential over the next several years. And when I asked him what it sourced from, he said, big data.”
Tom Russo Mar 11, 2019 ▶ 19:12 Thomas Russo – All About Google (Capital Allocators, EP.90)
Opinion
Russo: Juul's rise has increased business risk for Philip Morris
“I now know that with Juul's ascendancy, there is more risk to the business than there was when it was at a 120, and the product that they tried to launch was delayed, has consequences.”
Tom Russo Mar 11, 2019 ▶ 26:42 Thomas Russo – All About Google (Capital Allocators, EP.90)
Assertion Partly supported
Philip Morris's IQOS captured 25% of Japan's market in 18 months
“And as a result of those spending years, they developed a product that once launched, 18 months ago, has captured nearly 25% of markets in Japan, the first market it launched to. They've converted two million cigarette smokers to users of one of their new prod…”
Tom Russo Jul 10, 2017 ▶ 19:30 Thomas Russo – Buy and Hold...and Then What (Capital Allocators, EP.16)
Assertion Partly supported
Philip Morris invested $500 million annually into reduced-risk product research
“Philip Morris, four years ago, decided that they were going to take about half a billion dollars a year from their income statement. And deploy it into efforts to research and develop a reduced risk product set so that they could come to their consumers.”
Tom Russo Jul 10, 2017 ▶ 18:24 Thomas Russo – Buy and Hold...and Then What (Capital Allocators, EP.16)
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 700 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.